Sanofi Top Holdings and 13F Report (2026) About SanofiSanofi OTCMKTS: SNYNF has filed 13-F forms with the SEC as an investor. Sanofi is itself a publicly traded company. Sanofi is a France-based global healthcare company focused on the research, development, manufacturing and commercialization of pharmaceutical products and vaccines. Its portfolio includes medicines for immunology, rare diseases, neurology, oncology and other specialty-care areas, as well as treatments for common conditions such as diabetes and cardiovascular disease. For more information on Sanofi stock, visit the Sanofi stock profile here.Investment ActivitySanofi has $629.87 million in total holdings as of September 30, 2026.Sanofi owns shares of 16 different stocks, but just 7 companies or ETFs make up 80% of its holdings.Approximately 21.83% of the portfolio was purchased this quarter.About 0.01% of the portfolio was sold this quarter.This quarter, Sanofi has purchased 10 new stocks and bought additional shares in 0 stocks.Sanofi sold shares of 1 stock and completely divested from 0 stocks this quarter.Largest Holdings MeiraGTx $134,175,107Inhibrx Biosciences, Inc. $115,885,234Novavax $74,378,000Korsana Biosciences $63,808,352Odyssey Therapeutics Inc. $44,222,244 Largest New Holdings this Quarter 23255M303 - Korsana Biosciences $63,808,352 Holding284825106 - Electra Therapeutics Inc $27,696,915 Holding04987L102 - Attovia Therapeutics Inc $18,560,135 Holding517954103 - Latigo Biotherapeutics Inc $11,235,393 Holding811033109 - Scribe Therapeutics $9,202,500 Holding Largest Purchases this Quarter Korsana Biosciences 1,994,011 shares (about $63.81M)Electra Therapeutics Inc 2,461,948 shares (about $27.70M)Attovia Therapeutics Inc 1,082,855 shares (about $18.56M)Latigo Biotherapeutics Inc 672,778 shares (about $11.24M)Scribe Therapeutics 500,000 shares (about $9.20M) Largest Sales this Quarter Odyssey Therapeutics Inc. 1,718 shares (about $38.17K) Sector Allocation Over TimeMap of 500 Largest Holdings ofSanofi Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorMGTXMeiraGTx$134,175,1070.0%12,197,73721.3%HealthcareInhibrx Biosciences, Inc.$115,885,2340.0%1,157,92618.4%COMNVAXNovavax$74,378,0000.0%6,880,48111.8%HealthcareKorsana Biosciences$63,808,352$63,808,352 ▲New Holding1,994,01110.1%COMOdyssey Therapeutics Inc.$44,222,244$38,174 ▼-0.1%1,990,2007.0%COMMON STOCKANABAnaptysBio$41,309,5480.0%821,9176.6%HealthcareAgomab Therapeutics NV$30,892,3660.0%2,783,0964.9%SPONSORED ADSFirst Tracks Biotherapeutics Inc.$29,128,7380.0%821,9174.6%ORD SHSElectra Therapeutics Inc$27,696,915$27,696,915 ▲New Holding2,461,9484.4%COMAttovia Therapeutics Inc$18,560,135$18,560,135 ▲New Holding1,082,8552.9%COMLatigo Biotherapeutics Inc$11,235,393$11,235,393 ▲New Holding672,7781.8%COMIMRXImmuneering$11,091,5490.0%2,708,5591.8%HealthcareMapLight Therapeutics Inc.$9,293,6980.0%912,0411.5%COMScribe Therapeutics$9,202,500$9,202,500 ▲New Holding500,0001.5%COMSAB BIOTHERAPEUTICS INC$6,969,245$6,969,245 ▲New Holding2,198,5001.1%COM NEWQ32 Bio Inc.$2,018,5660.0%244,0830.3%COMShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.